Results: 3

1.
Figure 2

Figure 2. From: HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.

Kaplan–Meier survival plots of all type I and type II endometrial cancer patients with available clinical follow-up information (n=258) according to HER2 status (A), and EGFR status (B).

G E Konecny, et al. Br J Cancer. 2009 January 13;100(1):89-95.
2.
Figure 3

Figure 3. From: HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.

Kaplan–Meier survival plots of all type II endometrial cancer patients with available clinical follow-up information (n=133) according to HER2 status (A), and EGFR status (B).

G E Konecny, et al. Br J Cancer. 2009 January 13;100(1):89-95.
3.
Figure 1

Figure 1. From: HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.

(A) Kaplan–Meier survival plots of all type I and type II endometrial cancer patients with available clinical follow-up information (n=258) according to the histology type and (B) Kaplan–Meier survival plots among type II endometrial cancer patients with available follow up (n=133) according to FIGO stage.

G E Konecny, et al. Br J Cancer. 2009 January 13;100(1):89-95.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk